Hussein Abbas

50PUBLICATIONS
264CO-AUTHORS
Gene and molecular therapyHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Jul 06, 2026
Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II.

|Jun 11, 2026
All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE).

|May 21, 2026
Chromosome 5q deletion drives evolution of aneuploidy in myeloid neoplasms with complex karyotype.

|Apr 14, 2026
Integrated Analysis of Genomics, Molecular Responses, and Outcomes of CBF-AML with FLAG-Based Therapy on a Phase II Trial.

Jayastu Senapati, Hagop M Kantarjian, Edward Ayoub

|Apr 05, 2026
Midostaurin-Cladribine Therapy for Neonatal Aggressive Systemic Mastocytosis.

Maria Frost, Amr Elgehiny, Christopher Dobbins

|Mar 12, 2026
Immunophenotypic changes following menin inhibition in acute myeloid leukemia.

Sanam Loghavi, Aziz Farhat, Trevor J Jamison

Pageof 9

Frequent Collaborators

24 joint publications

Naval G Daver

21 joint publications

Courtney DiNardo

17 joint publications

Nicholas J Short

17 joint publications

Marina Y Konopleva